Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis
In 2009, vinflunine was introduced as a second-line treatment to be used after the failure of platinum therapy in patients with metastatic urothelial carcinoma (mUC). The present study investigated the administered vinflunine to patients with mUC in standard clinical practice with the aim of evaluat...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950730/ |